Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

The Second Messengers Ca2+ and cAMP as Potential Therapeutic Targets for the Control of Cancer Progression

Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Alberto Andrade Leite, Afonso Caricati-Neto and Leandro Bueno Bergantin*

Department of Pharmacology, Federal University of São Paulo-Paulista School of Medicine, Laboratory of Autonomic and Cardiovascular Pharmacology, Rua Pedro de Toledo669 - Vila Clementino, São Paulo-SP, Brazil

*Corresponding Author:
Leandro Bueno Bergantin
Department of Pharmacology, Federal University of São Paulo-Paulista School of Medicine
Laboratory of Autonomic and Cardiovascular Pharmacology
Rua Pedro de Toledo669 - Vila Clementino, São Paulo - SP, Brazil
Tel: 55 11 5576-4973
E-mail: leanbio39@yahoo.com.br

Received date: July 2, 2017; Accepted date: July 5, 2017; Published date: July 15, 2017

Citation: Errante PR, Rodrigues FSM, Leite AA, Caricati-Neto A, Bergantin LB (2017) The Second Messengers Ca2+ and camp as Potential Therapeutic Targets for the Control of Cancer Progression. Adv Cancer Prev 2:e105. doi:10.4172/2472-0429.1000e105

Copyright: © 2017 Errante PR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

This editorial highlights the relevance of interfering in cancer cell progression through the pharmacological manipulation on the cell metabolism of cyclic nucleotides such as cAMP, and on the intracellular Ca2+ signaling, which may avail the reduction of toxic effects promoted by chemotherapy, radiotherapy and immunotherapy, thus decreasing the incidence of interruption in antitumoral treatment.

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 352

Advances in Cancer Prevention received 352 citations as per Google Scholar report

Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Euro Pub
  • ICMJE
Share This Page
Top